NBRV - Nabriva Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts4477
Avg. Estimate-0.28-0.3-1.12-0.89
Low Estimate-0.33-0.36-1.28-1.2
High Estimate-0.21-0.23-0.72-0.54
Year Ago EPS-0.9-0.41-2.26-1.12
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts4467
Avg. Estimate1.05M2.21M9.95M31.09M
Low Estimate500k570k3.38M21M
High Estimate2.62M3.38M25M39.69M
Year Ago SalesN/A797k9.66M9.95M
Sales Growth (year/est)N/A177.30%3.00%212.50%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.29-0.32-0.32-0.33
EPS Actual-0.9-0.41-0.29-0.3
Difference-0.61-0.090.030.03
Surprise %-210.30%-28.10%9.40%9.10%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.28-0.3-1.12-0.89
7 Days Ago-0.28-0.31-1.12-0.89
30 Days Ago-0.33-0.34-1.19-0.92
60 Days Ago-0.32-0.32-1.2-0.93
90 Days Ago-0.32-0.32-1.2-0.93
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days2112
Up Last 30 Days4354
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/A21
Growth EstimatesNBRVIndustrySectorS&P 500
Current Qtr.68.90%N/AN/A-0.00
Next Qtr.26.80%N/AN/A0.08
Current Year50.40%N/AN/A0.03
Next Year20.50%N/AN/A0.10
Next 5 Years (per annum)97.20%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A